Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
GABA
GABA is an amino acid1 and the main inhibitory neurotransmitter in the mature mammalian central nervous system.2 It is also sold as a dietary supplement3 and commonly used for its calming effects. Unlike the amino acids incorporated into proteins,4 GABA is not an alpha amino acid.5 Whether supplemental GABA crosses the blood–brain barrier remains uncertain.3
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
GABA activates GABA-A and GABA-B receptors and primarily reduces neuronal excitability in the mature mammalian central nervous system.6 At GABA-A receptors, it opens chloride channels7; the direction of chloride movement determines whether its action is hyperpolarizing, depolarizing, or shunting, with shunting reducing the influence of other incoming signals. At GABA-B receptors, it regulates ion channels through G proteins and can also produce excitatory effects through activation of voltage-dependent calcium channels. GABA supports both rapid synaptic inhibition and slower tonic inhibition, while its effects in immature neurons can be excitatory because their chloride gradients differ.
GABA also regulates neural progenitor proliferation, migration, differentiation, and synapse formation, and GABA-A receptor activation can limit cell growth by arresting the cell cycle. In pancreatic islets, GABA inhibits glucagon secretion and can promote beta-cell replication and survival and the conversion of alpha cells to beta cells. It can suppress inflammatory immune responses and promote regulatory responses, with inhibition of autoimmune disease reported in several animal models. In rats, GABA enhances serotonin conversion toward a melatonin precursor, suggesting a possible role in melatonin synthesis.
Pharmacokinetics
The extent to which externally administered GABA crosses the blood-brain barrier remains uncertain, including in rat research.3 Systemically injected GABA can reach brain regions without an effective blood-brain barrier. GABA is metabolized by GABA transaminase in a reaction involving alpha-ketoglutarate.8 The resulting semialdehyde is oxidized by succinic semialdehyde dehydrogenase to a product that enters the citric acid cycle.9
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Toxicity
Use is not recommended during pregnancy and lactation because of possible biphasic effects on growth hormone production and other safety concerns.
History & Culture
GABA was first synthesized in 1883 and was initially known only as a metabolic product of plants and microbes.11 In 1950, Eugene Roberts and Sam Frankel at Washington University School of Medicine used newly developed chromatography techniques to study protein-free…
Legality
References
Citations
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the GABA article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.